vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and LCNB CORP (LCNB). Click either name above to swap in a different company.

Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $23.9M, roughly 1.0× LCNB CORP). LCNB CORP runs the higher net margin — 23.7% vs -54.6%, a 78.3% gap on every dollar of revenue. LCNB CORP produced more free cash flow last quarter ($33.4M vs $-11.0M).

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.

CBLL vs LCNB — Head-to-Head

Bigger by revenue
CBLL
CBLL
1.0× larger
CBLL
$24.8M
$23.9M
LCNB
Higher net margin
LCNB
LCNB
78.3% more per $
LCNB
23.7%
-54.6%
CBLL
More free cash flow
LCNB
LCNB
$44.4M more FCF
LCNB
$33.4M
$-11.0M
CBLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBLL
CBLL
LCNB
LCNB
Revenue
$24.8M
$23.9M
Net Profit
$-13.5M
$5.7M
Gross Margin
87.3%
Operating Margin
-58.9%
29.2%
Net Margin
-54.6%
23.7%
Revenue YoY
5.1%
Net Profit YoY
-7.6%
EPS (diluted)
$-0.35
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
LCNB
LCNB
Q4 25
$24.8M
$23.9M
Q3 25
$22.6M
$23.8M
Q2 25
$21.2M
$22.8M
Q1 25
$20.5M
$21.5M
Q4 24
$22.7M
Q3 24
$17.2M
$21.4M
Q2 24
$19.3M
Q1 24
$17.8M
Net Profit
CBLL
CBLL
LCNB
LCNB
Q4 25
$-13.5M
$5.7M
Q3 25
$-13.5M
$6.9M
Q2 25
$-13.6M
$5.9M
Q1 25
$-12.8M
$4.6M
Q4 24
$6.1M
Q3 24
$-10.4M
$4.5M
Q2 24
$925.0K
Q1 24
$1.9M
Gross Margin
CBLL
CBLL
LCNB
LCNB
Q4 25
87.3%
Q3 25
88.3%
Q2 25
88.1%
Q1 25
87.9%
Q4 24
Q3 24
87.3%
Q2 24
Q1 24
Operating Margin
CBLL
CBLL
LCNB
LCNB
Q4 25
-58.9%
29.2%
Q3 25
-64.8%
35.6%
Q2 25
-70.5%
31.6%
Q1 25
-69.3%
25.6%
Q4 24
32.9%
Q3 24
-57.8%
24.9%
Q2 24
4.9%
Q1 24
12.5%
Net Margin
CBLL
CBLL
LCNB
LCNB
Q4 25
-54.6%
23.7%
Q3 25
-59.6%
29.1%
Q2 25
-64.4%
26.0%
Q1 25
-62.4%
21.4%
Q4 24
27.0%
Q3 24
-60.6%
21.2%
Q2 24
4.8%
Q1 24
10.7%
EPS (diluted)
CBLL
CBLL
LCNB
LCNB
Q4 25
$-0.35
$0.40
Q3 25
$-0.37
$0.49
Q2 25
$-0.38
$0.41
Q1 25
$-0.36
$0.33
Q4 24
$0.44
Q3 24
$-1.85
$0.31
Q2 24
$0.07
Q1 24
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
LCNB
LCNB
Cash + ST InvestmentsLiquidity on hand
$159.3M
$21.6M
Total DebtLower is stronger
$104.4M
Stockholders' EquityBook value
$155.3M
$273.9M
Total Assets
$195.8M
$2.2B
Debt / EquityLower = less leverage
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
LCNB
LCNB
Q4 25
$159.3M
$21.6M
Q3 25
$168.5M
$35.9M
Q2 25
$177.4M
$49.8M
Q1 25
$182.7M
$37.7M
Q4 24
$35.7M
Q3 24
$14.1M
$39.4M
Q2 24
$34.9M
Q1 24
$33.0M
Total Debt
CBLL
CBLL
LCNB
LCNB
Q4 25
$104.4M
Q3 25
$104.7M
Q2 25
$105.0M
Q1 25
$104.6M
Q4 24
$155.2M
Q3 24
$155.7M
Q2 24
$162.2M
Q1 24
$162.6M
Stockholders' Equity
CBLL
CBLL
LCNB
LCNB
Q4 25
$155.3M
$273.9M
Q3 25
$164.1M
$269.9M
Q2 25
$172.2M
$263.5M
Q1 25
$180.9M
$258.7M
Q4 24
$253.0M
Q3 24
$-136.0M
$253.2M
Q2 24
$245.2M
Q1 24
$233.7M
Total Assets
CBLL
CBLL
LCNB
LCNB
Q4 25
$195.8M
$2.2B
Q3 25
$199.5M
$2.2B
Q2 25
$207.7M
$2.3B
Q1 25
$213.5M
$2.3B
Q4 24
$2.3B
Q3 24
$47.1M
$2.3B
Q2 24
$2.4B
Q1 24
$2.3B
Debt / Equity
CBLL
CBLL
LCNB
LCNB
Q4 25
0.38×
Q3 25
0.39×
Q2 25
0.40×
Q1 25
0.40×
Q4 24
0.61×
Q3 24
0.61×
Q2 24
0.66×
Q1 24
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
LCNB
LCNB
Operating Cash FlowLast quarter
$-10.8M
$34.4M
Free Cash FlowOCF − Capex
$-11.0M
$33.4M
FCF MarginFCF / Revenue
-44.2%
140.2%
Capex IntensityCapex / Revenue
0.7%
4.0%
Cash ConversionOCF / Net Profit
6.08×
TTM Free Cash FlowTrailing 4 quarters
$-41.6M
$54.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
LCNB
LCNB
Q4 25
$-10.8M
$34.4M
Q3 25
$-11.1M
$14.0M
Q2 25
$-7.5M
$5.5M
Q1 25
$-11.4M
$2.2M
Q4 24
$93.2M
Q3 24
$11.9M
Q2 24
$54.9M
Q1 24
$-11.9M
Free Cash Flow
CBLL
CBLL
LCNB
LCNB
Q4 25
$-11.0M
$33.4M
Q3 25
$-11.5M
$13.7M
Q2 25
$-7.6M
$5.2M
Q1 25
$-11.6M
$2.1M
Q4 24
$89.4M
Q3 24
$10.5M
Q2 24
$53.8M
Q1 24
$-12.8M
FCF Margin
CBLL
CBLL
LCNB
LCNB
Q4 25
-44.2%
140.2%
Q3 25
-50.8%
57.4%
Q2 25
-35.9%
23.0%
Q1 25
-56.4%
10.0%
Q4 24
394.0%
Q3 24
49.0%
Q2 24
278.6%
Q1 24
-71.8%
Capex Intensity
CBLL
CBLL
LCNB
LCNB
Q4 25
0.7%
4.0%
Q3 25
1.6%
1.3%
Q2 25
0.3%
1.0%
Q1 25
0.7%
0.3%
Q4 24
16.7%
Q3 24
6.7%
Q2 24
5.9%
Q1 24
4.8%
Cash Conversion
CBLL
CBLL
LCNB
LCNB
Q4 25
6.08×
Q3 25
2.02×
Q2 25
0.92×
Q1 25
0.48×
Q4 24
15.23×
Q3 24
2.63×
Q2 24
59.35×
Q1 24
-6.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

LCNB
LCNB

Segment breakdown not available.

Related Comparisons